Danaher/Abcam: Deal Not Attracting Industry Complaints So Far in Sped-Up Review

Published on Oct 26, 2023

Danaher’s (DHR) planned $5.7 billion acquisition of Abcam (ABCM) hasn’t generated significant industry complaints so far as China’s antitrust authority, under its sped-up review process, starts seeking public comment about the tie-up, sources familiar with the matter said. Due to the limited product overlaps it would create, the transaction isn’t likely to raise significant antitrust […]

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

© 2024 the Capitol Forum